Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Baech, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen & Thomas Stauffer Larsen. (2022) Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study. Leukemia & Lymphoma 63:9, pages 2074-2083.
Read now
Read now
Megan Melody, Sangeetha Gandhi, Hollie Saunders, Zaid Abdel-Rahman, Jacquelyn Hastings, Paula Lengerke Diaz, Nicole Gannon, Tuan Truong, Matthew Hathcock, Arushi Khurana, Patrick Johnston, Stephen Ansell, Nora Bennani, Jonas Paludo, Jose Villasboas Bisneto, Yucai Wang, Allison Rosenthal, James Foran, Ernesto Ayala, Hemant S. Murthy, Vivek Roy, Januario E. Castro, Yi Lin & Mohamed A. Kharfan-Dabaja. (2022) Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience. Leukemia & Lymphoma 63:6, pages 1363-1368.
Read now
Read now
Kate L. Burbury, Marliese Alexander & David A. Westerman. (2016) Risk of thromboembolism with lymphoma: myth or reality?. Leukemia & Lymphoma 57:12, pages 2736-2738.
Read now
Read now
Ina Hornemann Borg, Mette Dahl Bendtsen, Martin Bøgsted, Jakob Madsen & Marianne Tang Severinsen. (2016) Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:12, pages 2771-2776.
Read now
Read now
Brandon McMahon. (2009) Malignancy-Associated Thrombosis. Oncology Issues 24:1, pages 20-23.
Read now
Read now
Anna Falanga, Alfonso Vignoli & Marina Marchetti. (2009) Coagulation in Hematological Malignancies. Cancer Investigation 27:sup1, pages 7-16.
Read now
Read now
Articles from other publishers (66)
Juliette Pénichoux, Julien Rio, Leila Kammoun, Thomas Vermeulin, Louis‐Ferdinand Pepin, Vincent Camus, Sydney Dubois, Florian Bouclet, Mustafa Alani, Nathalie Contentin, Stéphane Leprêtre, Aspasia Stamatoullas, Hélène Lanic, Emilie Lemasle, Anne‐Lise Ménard, Pascal Lenain, Marie Gilles‐Baray, Dragos Georgescu, Florian Clatot, Hervé Tilly & Fabrice Jardin. (2022) Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first‐line treatment for patients with diffuse large B‐cell lymphoma. European Journal of Haematology 109:1, pages 41-49.
Crossref
Crossref
Radhika Gangaraju, Elizabeth S. Davis, Smita Bhatia & Kelly M. Kenzik. (2022) Venous‐thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma. Cancer 128:12, pages 2348-2357.
Crossref
Crossref
Kristen M. Sanfilippo. (2022) Venous thromboembolism and risk stratification in hematological malignancies. Thrombosis Research 213, pages S16-S21.
Crossref
Crossref
Yingxia Lan, Jinqiu Guan, Jia Zhu, Juan Wang, Mengzhen Li, Chengtao Sun, Feifei Sun, Junting Huang, Suying Lu & Yizhuo Zhang. (2021) Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features. Leukemia Research 103, pages 106537.
Crossref
Crossref
Xiao Li, Shu-Ling Hou, Xi Li, Li Li, Ke Lian, Ju-Ya Cui, Gang-Gang Wang & Tao Yang. (2021) Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962110379.
Crossref
Crossref
Benjamín Rubio-Jurado, Lluvia Sugey Sosa-Quintero, Sandra Guzmán-Silahua, Eduardo García-Luna, Carlos Riebeling-Navarro & Arnulfo Hernán Nava-Zavala. 2021.
213
242
.
Arafat Ul Alam, Mohammad Karkhaneh, Haowei (Linda) Sun & Cynthia Wu. (2020) Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015. Thrombosis Research.
Crossref
Crossref
Stefan Hohaus, Francesca Bartolomei, Annarosa Cuccaro, Elena Maiolo, Eleonora Alma, Francesco D’Alò, Silvia Bellesi, Elena Rossi & Valerio De Stefano. (2020) Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis. Cancers 12:5, pages 1291.
Crossref
Crossref
Claudia I. Chapuy & Jean M. Connors. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
523
543.e7
.
Ja Min Byun, Junshik Hong, Sung-Soo Yoon, Youngil Koh, Chan-Young Ock, Tae Min Kim, Ji Hyun Lee, Sung-Hyun Kim, Jeong-Ok Lee, Soo-Mee Bang, Ho-Young Yhim, Sung Hwa Bae, Yeung-Chul Mun & Doyeun Oh. (2019) Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy. Thrombosis Research 183, pages 131-135.
Crossref
Crossref
S. Borchmann, H. Müller, I. Hude, M. Fuchs, P. Borchmann & A. Engert. (2019) Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials. Annals of Oncology 30:8, pages 1329-1334.
Crossref
Crossref
Natasha Kekre & Jean M. Connors. (2019) Venous thromboembolism incidence in hematologic malignancies. Blood Reviews 33, pages 24-32.
Crossref
Crossref
Rachel J. David, Andrea Baran, Kah Poh Loh, Carla Casulo, Paul M. Barr, Jonathan W. Friedberg & Patrick M. Reagan. (2018) Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:12, pages 781-787.
Crossref
Crossref
Alberto Zanetto, Elena Campello, Luca Spiezia, Patrizia Burra, Paolo Simioni & Francesco Russo. (2018) Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. Cancers 10:11, pages 450.
Crossref
Crossref
Yuchen Wang, B. M. Attar, K. Hinami, H. E. Fuentes, P. Jaiswal, H. Zhang, C. S. Simons-Linares & A. J. Tafur. (2017) Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 49:3, pages 275-282.
Crossref
Crossref
A. S. Fedorova, V. V. Dmitriev, N. V. Lipay, A. F. Markоvets, I. V. Begun & E. V. Dmitriev. (2018) VENOUS THROMBOSIS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS: INCIDENCE, CHARACTERISTICS, RISK FACTORS AND PROGNOSTIC VALUE. Oncohematology 13:2, pages 9-20.
Crossref
Crossref
Joanna Rupa-Matysek, Lidia Gil, Marta Barańska, Dominik Dytfeld & Mieczysław Komarnicki. (2018) Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma. Oncotarget 9:30, pages 21190-21200.
Crossref
Crossref
Darko Antic, Jelena Jelicic, Vojin Vukovic, Srdjan Nikolovski & Biljana Mihaljevic. (2018) Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment. Blood Reviews 32:2, pages 144-158.
Crossref
Crossref
Benjamín Rubio-Jurado, Luz-Ma-Adriana Balderas-Peña, Eduardo E. García-Luna, María G. Zavala-Cerna, Carlos Riebeling-Navarro, Pedro A. Reyes & Arnulfo H. Nava-Zavala. 2018.
71
89
.
Joanna Rupa-Matysek, Lidia Gil, Maciej Kaźmierczak, Marta Barańska & Mieczysław Komarnicki. (2017) Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score. Medical Oncology 35:1.
Crossref
Crossref
Joanna Rupa-Matysek, Lidia Gil, Renata Kroll-Balcerzak, Marta Barańska & Mieczysław Komarnicki. (2017) Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma. Hematological Oncology 35:4, pages 456-464.
Crossref
Crossref
J.H. Lee, J. Lee, H.‐Y. Yhim, D. Oh & S.‐M. Bang. (2017) Venous thromboembolism following L‐asparaginase treatment for lymphoid malignancies in Korea. Journal of Thrombosis and Haemostasis 15:4, pages 655-661.
Crossref
Crossref
Gary H. Lyman, Anna Catino & Bonnie Ky. 2017. Cardio-Oncology. Cardio-Oncology
215
240
.
Waqas Qureshi, Zeeshan Ali, Waseem Amjad, Zaid Alirhayim, Hina Farooq, Shayan Qadir, Fatima Khalid & Mouaz H. Al-Mallah. (2016) Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants. Frontiers in Cardiovascular Medicine 3.
Crossref
Crossref
Nicole M. Kuderer, Eva Culakova, Gary H. Lyman, Charles Francis, Anna Falanga & Alok A. Khorana. (2016) A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality. The Oncologist 21:7, pages 861-867.
Crossref
Crossref
K.M. Sanfilippo, T.F. Wang, B.F. Gage, S. Luo, P. Riedell & K.R. Carson. (2016) Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma. Thrombosis Research 143, pages 86-90.
Crossref
Crossref
Xi Zhang, Jia-Jia Huang, Yi Xia, Chao-Feng Li, Yu Wang, Pan-Pan Liu, Xi-Wen Bi, Peng Sun, Tong-Yu Lin, Wen-Qi Jiang & Zhi-Ming Li. (2016) High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. Oncotarget 7:23, pages 35404-35411.
Crossref
Crossref
Harry E. Fuentes, Alfonso J. Tafur & Joseph A. Caprini. (2016) Cancer-associated thrombosis. Disease-a-Month 62:5, pages 121-158.
Crossref
Crossref
Sung Hee Lim, Sook-young Woo, Seonwoo Kim, Young Hyeh Ko, Won Seog Kim & Seok Jin Kim. (2016) Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism. Cancer Research and Treatment 48:1, pages 312-321.
Crossref
Crossref
M. Šimkovič, P. Vodárek, M. Motyčková, D. Belada, F. Vrbacký, P. Žák & L. Smolej. (2015) Venous thromboembolism in patients with chronic lymphocytic leukemia. Thrombosis Research 136:6, pages 1082-1086.
Crossref
Crossref
Jennifer L. Lund, Lene Sofie Østgård, Paolo Prandoni, Henrik Toft Sørensen & Peter de Nully Brown. (2015) Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark. Thrombosis Research 136:5, pages 917-923.
Crossref
Crossref
Tanya M. Petterson, Randolph S. Marks, Aneel A. Ashrani, Kent R. Bailey & John A. Heit. (2015) Risk of site-specific cancer in incident venous thromboembolism: A population-based study. Thrombosis Research 135:3, pages 472-478.
Crossref
Crossref
Kenji Yokoyama. (2015) Thrombosis in Lymphoma Patients and in Myeloma Patients. The Keio Journal of Medicine 64:3, pages 37-43.
Crossref
Crossref
Riccardo Colombo, Paolo Gallipoli & Roberto Castelli. (2014) Thrombosis and Hemostatic Abnormalities in Hematological Malignancies. Clinical Lymphoma Myeloma and Leukemia 14:6, pages 441-450.
Crossref
Crossref
Gary H. Lyman. (2014) Impact of venous thromboembolism on survival in patients with advanced cancer: an unmet clinical need. Internal and Emergency Medicine 9:5, pages 497-499.
Crossref
Crossref
Nicole M. Kuderer & Gary H. Lyman. (2014) Guidelines for treatment and prevention of venous thromboembolism among patients with cancer. Thrombosis Research 133, pages S122-S127.
Crossref
Crossref
Anjlee Mahajan, Ted Wun, Helen Chew & Richard H. White. (2014) Lymphoma and venous thromboembolism: influence on mortality. Thrombosis Research 133, pages S23-S28.
Crossref
Crossref
Amer M. Zeidan, Patrick M. Forde & Michael B. Streiff. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
542
561.e7
.
Gregory C. Connolly & Alok A. Khorana. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
408
422
.
Roy E. StrowdIIIIII, Mary Ann Knovich & Glenn J. Lesser. (2012) The Therapeutic Management of Bleeding and Thrombotic Disorders Complicating CNS Malignancies. Current Treatment Options in Oncology 13:4, pages 451-464.
Crossref
Crossref
Anna Falanga, Marina Marchetti & Laura Russo. (2012) Venous thromboembolism in the hematologic malignancies. Current Opinion in Oncology 24:6, pages 702-710.
Crossref
Crossref
Lee Chun Park, Sook-young Woo, Seonwoo Kim, Hyejin Jeon, Young Hyeh Ko, Seok Jin Kim & Won Seog Kim. (2012) Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population. Thrombosis Research 130:3, pages e6-e12.
Crossref
Crossref
Kenji Yokoyama, Mitsuru Murata, Yasuo Ikeda & Shinichiro Okamoto. (2012) Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. Thrombosis Research 130:1, pages 7-11.
Crossref
Crossref
F. Elice & F. Rodeghiero. (2012) Hematologic malignancies and thrombosis. Thrombosis Research 129:3, pages 360-366.
Crossref
Crossref
Myoung Joo Kang, Baek-Yeol Ryoo, Min-Hee Ryu, Dong-Hoe Koo, Heung Moon Chang, Jae-Lyun Lee, Tae Won Kim & Yoon-Koo Kang. (2012) Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience. European Journal of Cancer 48:4, pages 492-500.
Crossref
Crossref
Gary H. Lyman. (2010) Venous thromboembolism in the patient with cancer. Cancer 117:7, pages 1334-1349.
Crossref
Crossref
Tarek Sousou & Alok A. Khorana. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies
449
459
.
Danijela Lekovic, Predrag Miljic & Biljana Mihaljevic. (2010) Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. Thrombosis Research 126:6, pages 477-480.
Crossref
Crossref
Xiao Zhou, Shyam Teegala, Auris Huen, Yuan Ji, Luis Fayad, Fredrick B. Hagemeister, Gregory Gladish & Saroj Vadhan-Raj. (2010) Incidence and Risk Factors of Venous Thromboembolic Events in Lymphoma. The American Journal of Medicine 123:10, pages 935-941.
Crossref
Crossref
Vanesa Caruso, Augusto Di Castelnuovo, Susana Meschengieser, Maria A. Lazzari, Giovanni de Gaetano, Sergio Storti, Licia Iacoviello & Maria Benedetta Donati. (2010) Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood 115:26, pages 5322-5328.
Crossref
Crossref
Alok A. Khorana. (2010) Venous thromboembolism and prognosis in cancer. Thrombosis Research 125:6, pages 490-493.
Crossref
Crossref
Gary H. Lyman & Nicole M. Kuderer. (2010) Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines. Thrombosis Research 125, pages S120-S127.
Crossref
Crossref
Ted Wun & Richard H. White. (2010) Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thrombosis Research 125, pages S96-S102.
Crossref
Crossref
Gregory C. Connolly & Alok A. Khorana. (2010) Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thrombosis Research 125, pages S1-S7.
Crossref
Crossref
Anna FalangaMarina Marchetti. (2009) Venous Thromboembolism in the Hematologic Malignancies. Journal of Clinical Oncology 27:29, pages 4848-4857.
Crossref
Crossref
Alok A. KhoranaGregory C. Connolly. (2009) Assessing Risk of Venous Thromboembolism in the Patient With Cancer. Journal of Clinical Oncology 27:29, pages 4839-4847.
Crossref
Crossref
Naureen StarlingSheela RaoDavid CunninghamTimothy IvesonMarianne NicolsonFareeda CoxonGary MiddletonFrancis DanielJacqueline OatesAndrew Richard Norman. (2009) Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. Journal of Clinical Oncology 27:23, pages 3786-3793.
Crossref
Crossref
Gregory C. Connolly & Alok A. Khorana. (2009) Risk stratification for cancer-associated venous thromboembolism. Best Practice & Research Clinical Haematology 22:1, pages 35-47.
Crossref
Crossref
Maithili V Rao, Charles W Francis & Alok A Khorana. 2008. Cancer Supportive Care: Advances in Therapeutic Strategies. Cancer Supportive Care: Advances in Therapeutic Strategies
1
29
.
Gregory C. Connolly, Rui Chen, Ollivier Hyrien, Parvez Mantry, Adel Bozorgzadeh, Peter Abt & Alok A. Khorana. (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thrombosis Research 122:3, pages 299-306.
Crossref
Crossref
Gary Lyman & Nicole Kuderer. 2007. Cancer-Associated Thrombosis. Cancer-Associated Thrombosis
255
272
.
Maithili "Rao,"Charles "Francis,". 2007. Cancer-Associated Thrombosis. Cancer-Associated Thrombosis
169
191
.
Anna Falanga & Marina Marchetti. 2007. Cancer-Associated Thrombosis. Cancer-Associated Thrombosis
131
149
.
Hau C. Kwaan & Brian Vicuna. (2007) Thrombosis and bleeding in cancer patients. Oncology Reviews 1:1, pages 14-27.
Crossref
Crossref
Julio García-Suárez, Helena Bañas, Ignacio Arribas, Dunia De Miguel, Teresa Pascual & Carmen Burgaleta. (2007) Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study. British Journal of Haematology 136:2, pages 276-285.
Crossref
Crossref
Alok A. Khorana & Maithili V. Rao. (2007) Approaches to risk-stratifying cancer patients for venous thromboembolism. Thrombosis Research 120, pages S41-S50.
Crossref
Crossref